This compound is primarily utilized in organic synthesis as a key intermediate in the production of more complex molecules, particularly in the pharmaceutical industry. It serves as a building block for the development of active pharmaceutical ingredients (APIs), especially those targeting neurological and cardiovascular diseases. Its structure, featuring a bromophenyl group and a tert-butoxycarbonyl (Boc) protected amino group, makes it valuable for peptide coupling reactions and the synthesis of chiral compounds. Additionally, it is employed in research settings for the study of enzyme inhibitors and receptor modulators, contributing to the development of novel therapeutic agents. Its role in asymmetric synthesis also highlights its importance in creating enantiomerically pure drugs.